Rebecca Byam Hcw Biologics Inc. (HCWB) insider trading activity

Rebecca Byam is Chief Financial Officer of HCW Biologics Inc.. Currently has a direct ownership of 1.38 Million shares of HCWB, which is worth approximately $704,773. The most recent transaction as insider was on Aug 26, 2022, when has been sold 10,000 shares (Common Stock) at a price of $2.54 per share, resulting in proceeds of $25,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.38M

0% 3M change

140.77% 12M change

Total Value Held $704,773

Rebecca Byam Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 26 2022	BUY Open market or private purchase	$25,400 $2.54 p/Share	10,000 Added 3.76%	255,752 Common Stock
Aug 25 2022	BUY Open market or private purchase	$104,377 $2.59 p/Share	40,300 Added 14.09%	245,752 Common Stock
Aug 24 2022	BUY Open market or private purchase	$125,000 $2.5 p/Share	50,000 Added 19.57%	205,452 Common Stock
Jun 14 2022	BUY Open market or private purchase	$144,786 $2.46 p/Share	58,856 Added 27.46%	155,452 Common Stock
Jun 13 2022	BUY Open market or private purchase	$15,800 $2.08 p/Share	7,596 Added 7.29%	96,596 Common Stock
Nov 23 2021	BUY Exercise of conversion of derivative security	$3,780 $0.14 p/Share	27,000 Added 23.28%	89,000 Common Stock
Aug 19 2021	BUY Open market or private purchase	$44,000 $4.4 p/Share	10,000 Added 13.89%	62,000 Common Stock
Jul 22 2021	BUY Open market or private purchase	$200,000 $8.0 p/Share	25,000 Added 32.47%	52,000 Common Stock

Rebecca Byam

Chief Financial Officer

Miramar, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCWB shares.

Notify only if

Value

Insider Trading

Get notified when an Hcw Biologics Inc. insider buys or sells HCWB shares.

Notify only if

Operation

Value

Type

News

Receive news related to HCW Biologics Inc.

Track Activities on HCWB

Account